A world-first scientific study has shown that whole genome sequencing can uncover new diagnoses for people across the broadest range of rare diseases investigated to date.
Read more
Results from a COVID-19 vaccine trial – to which MFT consented the first global participant – are ‘extremely positive’.
Read more
Saint Mary's researchers have revealed new ways of calculating older mums’ personal risk of serious pregnancy problems like having stillborn, premature, or very small babies.
Read more
Research led by Professor Bill Newman, Consultant at MFT, could revolutionise the diagnosis and treatment for people with Perrault syndrome.
Read more
Children with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.
Read more
Pioneering care and research across Manchester University Hospitals NHS Foundation Trust (MFT) features in a new national exhibition on cancer breakthroughs.
Read more
Implantable heart technology is being used in Manchester to assess when a patient is at high risk of dying, thanks to Manchester University NHS Foundation Trust-led research.
Read more
Manchester University NHS Foundation Trust (MFT) has appointed new leadership of its Diagnostics and Technology Accelerator (DiTA).
Read more
